Introduction: The history of arsenic trioxide in cancer therapy

Oncologist

Volumn 6, Issue SUPPL. 2, 2001, Pages 1-2

  Antman, Karen H ^a,b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b Milstein Hospital   (United States)

Author keywords

Acute promyelocytic leukemia; Arsenic trioxide chemotherapy; Cancer; Leukemia

Indexed keywords

ARSENIC TRIOXIDE; ARSPHENAMINE;

CANCER THERAPY; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SYPHILIS; TRYPANOSOMIASIS;

EID: 0035031195     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.6-suppl_2-1     Document Type: Conference Paper

References (14)

1. Heavy metals and heavy-metal antagonists
2. Arsenic and old myths
3. Delicious poison: Arsenic trioxide for the treatment of leukemia
4. Arsenic - New life for an old potion
5. Arsenic poisoning of Bangladesh groundwater [scientific correspondence]
6. Action of iron, cod-liver oil, and arsenic on the globular richness of the blood
7. Arsenic as a therapeutic agent in chronic myelogenous leukemia
8. Ai-Lin 1 treated 32 cases of acute promyelocytic leukemia
9. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia
10. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
11. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
12. U.S. multicenter trial of arsenic trioxide (AT) in acute promyelocytic leukemia (APL)